BIRD
Allbirds, Inc.
There isn't enough reported data to score BIRD yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
BIRD Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Under pressure | |
| Unavailable |
BIRD's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BIRD PE Valuation
BIRD has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BIRD Forward outlook
There aren't enough analyst estimates for BIRD to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BIRD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$8.98 | +$1.54 |
| Q1 2026 | -$9.11 | +$1.89 |
| Q4 2025 | -$9.47 | +$2.40 |
| Q3 2025 | -$10.33 | +$5.95 |
| Q2 2025 | -$10.52 | +$7.28 |
| Q1 2025 | -$11.00 | +$8.20 |
| Q4 2024 | -$11.87 | +$8.33 |
| Q3 2024 | -$16.28 | -$0.48 |
BIRD has the edge over LCID on earnings, with more consistent year-over-year improvement.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BIRD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.8M | -93% |
| Q1 2026 | $22.3M | -31% |
| Q4 2025 | $47.7M | -15% |
| Q3 2025 | $33M | -23% |
| Q2 2025 | $39.7M | -23% |
| Q1 2025 | $32.1M | -18% |
| Q4 2024 | $55.9M | -22% |
| Q3 2024 | $43M | -25% |
BIRD's revenue has slid since its 2021 peak: $3M last quarter, down 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -388% | -346 points |
| Q1 2026 | -99% | -28 points |
| Q4 2025 | -43% | +2.7 points |
| Q3 2025 | -60% | -9.6 points |
| Q2 2025 | -42% | -2.5 points |
| Q1 2025 | -71% | +4.7 points |
| Q4 2024 | -46% | +34 points |
| Q3 2024 | -51% | +1.9 points |
BIRD's operating margin was −388% last quarter, down 346 points from the same quarter a year ago, near the bottom of its range since 2020.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BIRD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID has the edge over BIRD on profitability, with a higher operating margin.
BIRD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.1M | +$11.5M |
| Q1 2026 | -$12.1M | +$16.4M |
| Q4 2025 | -$4.1M | +$7.7M |
| Q3 2025 | -$16.1M | -$4.3M |
| Q2 2025 | -$9.4M | +$7.5M |
| Q1 2025 | -$28.5M | -$1.2M |
| Q4 2024 | -$11.9M | -$5.9M |
| Q3 2024 | -$11.9M | -$4.4M |
BIRD has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BIRD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.9% | +428K shares |
| 1 year | +13% | +1.1M shares |
| 3 years | +22% | +1.6M shares |
| 5 years | +44% | +2.8M shares |
BIRD has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BIRD Net Leverage
BIRD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BIRD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.3 | Neutral |
| Stochastic | 1.2 | Oversold |
BIRD's weekly RSI is 36 (neutral) and its Stochastic is 1 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BIRD PE vs Consumer Cyclical Sector
BIRD has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BIRD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.21 | 50% below |
| 20 week MA | $2.47 | 55% below |
| 50 week MA | $3.54 | 69% below |
| 100 week MA | $5.28 | 79% below |
| 200 week MA | $13.0 | 91% below |
BIRD is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BIRD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $520.6 | $355.0 | -32% |
| 2022 | $355.0 | $47.8 | -87% |
| 2023 | $47.8 | $24.6 | -49% |
| 2024 | $24.6 | $7.39 | -70% |
| 2025 | $7.39 | $4.05 | -45% |
| 2026 YTD | $4.05 | $1.11 | -73% |
BIRD has finished every year since 2021 lower, and it's down 73% so far in 2026.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has the edge over BIRD on returns for 2026, with the stronger performance.